Structure and Function of Human Cytochrome P450 8B1 Jinghan Liu Advisor: Dr

Total Page：16

File Type：pdf, Size：1020Kb

Structure and Function of Human Cytochrome P450 8B1 Jinghan Liu Advisor: Dr. Emily Scott Tuesday February 2, 2021, 4:00 p.m. Human Cytochrome P450 8B1 (CYP8B1) is involved in the conversion of cholesterol to bile acids. It specifically hydroxylates the steroid ring system at C12 to produce the bile acid cholic acid. As such, CYP8B1 activity controls the ratio of cholic acid over another bile acid called chenodeoxycholic acid. The ratio of these two bile acids controls the overall hydrophobicity of the bile pool and the signaling through the farnesoid X receptor (FXR). Recent studies knocking out CYP8B1 implicated this enzyme as a good drug target for nonalcoholic fatty liver disease and type 2 diabetes. However, there are no selective inhibitors known for this enzyme, which restricts the further study of this enzyme and potential disease treatment. There are also no structures of CYP8B1 to guide the development of such inhibitors. Herein the CYP8B1 protein was generated recombinantly in E. coli from a synthetic engineered gene, purified to homogeneity, and characterized. The resulting protein was catalytically active and displayed normal spectral features. Changes in the absorbance spectra were used to evaluate the binding of multiple ligands. The tight-binding non-selective CYP8B1 inhibitor tioconazole was identified and then used to solve the first available X-ray structure of CYP8B1 (Figure 1 A). This structure reveals the (S)-tioconazole imidazole A B nitrogen forming a coordinate covalent W281 bond to the CYP8B1 heme iron, consistent with enzyme inhibition N286 (Figure 1B). The ligand is close towards the B’ helix due to the spatial hinderance of W281 and Figure 1. Structure of CYP8B1 with its non-selective inhibitor. A) Overall structure of CYP8B1 N286 on the opposite rainbow-colored from blue N terminus to the red C terminus. B) (S)-tioconazole binding. side of the active site (Figure 1B). The availability of the CYP8B1 active site architecture should aid structure-based design of inhibitors that selectively bind CYP8B1 vs. other closely related P450 enzymes. Selective inhibitors should promote a better understanding of the role of CYP8B1 inhibition in these normal physiology and disease states and provide a possible treatment for nonalcoholic fatty liver disease and type 2 diabetes. .

Copy Link

Recommended publications

Identification and Developmental Expression of the Full Complement Of
Goldstone et al. BMC Genomics 2010, 11:643 http://www.biomedcentral.com/1471-2164/11/643 RESEARCH ARTICLE Open Access Identification and developmental expression of the full complement of Cytochrome P450 genes in Zebrafish Jared V Goldstone1, Andrew G McArthur2, Akira Kubota1, Juliano Zanette1,3, Thiago Parente1,4, Maria E Jönsson1,5, David R Nelson6, John J Stegeman1* Abstract Background: Increasing use of zebrafish in drug discovery and mechanistic toxicology demands knowledge of cytochrome P450 (CYP) gene regulation and function. CYP enzymes catalyze oxidative transformation leading to activation or inactivation of many endogenous and exogenous chemicals, with consequences for normal physiology and disease processes. Many CYPs potentially have roles in developmental specification, and many chemicals that cause developmental abnormalities are substrates for CYPs. Here we identify and annotate the full suite of CYP genes in zebrafish, compare these to the human CYP gene complement, and determine the expression of CYP genes during normal development. Results: Zebrafish have a total of 94 CYP genes, distributed among 18 gene families found also in mammals. There are 32 genes in CYP families 5 to 51, most of which are direct orthologs of human CYPs that are involved in endogenous functions including synthesis or inactivation of regulatory molecules. The high degree of sequence similarity suggests conservation of enzyme activities for these CYPs, confirmed in reports for some steroidogenic enzymes (e.g. CYP19, aromatase; CYP11A, P450scc; CYP17, steroid 17a-hydroxylase), and the CYP26 retinoic acid hydroxylases. Complexity is much greater in gene families 1, 2, and 3, which include CYPs prominent in metabolism of drugs and pollutants, as well as of endogenous substrates.
[Show full text]
Hepatic Gene Expression of Bile Acid Synthesis Genes from Wild-Type and Fxr−/− Mice
A 2.0 Acox2 B 2.0 Akr1c14 C 2.0 Akr1d1 D 2.0 Amacr ** 1.5 1.5 1.5 1.5 1.0 1.0 1.0 1.0 0.5 0.5 0.5 0.5 mRNA (Fold Change) mRNA mRNA (Fold Change) mRNA mRNA (Fold Change) mRNA mRNA (Fold Change) mRNA 0.0 0.0 0.0 0.0 GSK − 30’ 1h 2h − 30’ 1h 2h GSK − 30’ 1h 2h − 30’ 1h 2h GSK − 30’ 1h 2h − 30’ 1h 2h GSK − 30’ 1h 2h − 30’ 1h 2h FXR WT Fxr−/− FXR WT Fxr−/− FXR WT Fxr−/− FXR WT Fxr−/− E F 2.0 Cyp7b1 2.0 Cyp27a1 G 2.0 Cyp39a1 H 2.0 Hsd3b7 1.5 1.5 1.5 1.5 * 1.0 1.0 1.0 1.0 0.5 0.5 0.5 0.5 mRNA (Fold Change) mRNA mRNA (Fold Change) mRNA mRNA (Fold Change) mRNA mRNA (Fold Change) mRNA 0.0 0.0 0.0 0.0 GSK − 30’ 1h 2h − 30’ 1h 2h GSK − 30’ 1h 2h − 30’ 1h 2h GSK − 30’ 1h 2h − 30’ 1h 2h GSK − 30’ 1h 2h − 30’ 1h 2h FXR WT Fxr−/− FXR WT Fxr−/− FXR WT Fxr−/− FXR WT Fxr−/− I J K 2.0 Hsd17b4 2.0 Scp2 2.0 Slc27a5 L Fxr Cyp7a1 Cyp8b1 1.0 1.5 1.5 1.5 * 1.0 1.0 1.0 0.5 *** *** 0.5 0.5 0.5 mRNA (Fold Change) mRNA mRNA (Fold Change) mRNA mRNA (Fold Change) mRNA mRNA (Fold Change) mRNA *** *** *** 0.0 0.0 0.0 0.0 *** GSK − 30’ 1h 2h − 30’ 1h 2h GSK − 30’ 1h 2h − 30’ 1h 2h GSK − 30’ 1h 2h − 30’ 1h 2h Time (h) 0 4 16 0 4 16 0 4 16 FXR WT Fxr−/− FXR WT Fxr−/− FXR WT Fxr−/− post plating M N CYP7A1 CYP8B1 Supplementary Figure 1 – FXR activation leads to rapid changes in gene expression 1.0 1.0 (A-K) Hepatic gene expression of bile acid synthesis genes from wild-type and Fxr−/− mice.
[Show full text]
TRANSLATIONALLY by AMPK a Dissertation
CHOLESTEROL 7 ALPHA-HYDROXYLASE IS REGULATED POST- TRANSLATIONALLY BY AMPK A dissertation submitted to Kent State University in partial fulfillment of the requirements for the Degree of Doctor of Philosophy By Mauris E.C. Nnamani May 2009 Dissertation written by Mauris E. C. Nnamani B.S, Kent State University, 2006 Ph.D., Kent State University, 2009 Approved by Diane Stroup Advisor Gail Fraizer Members, Doctoral Dissertation Committee S. Vijayaraghavan Arne Gericke Jennifer Marcinkiewicz Accepted by Robert Dorman , Director, School of Biomedical Science John Stalvey , Dean, Collage of Arts and Sciences ii TABLE OF CONTENTS LIST OF FIGURES……………………………………………………………..vi ACKNOWLEDGMENTS……………………………………………………..viii CHAPTER I: INTRODUCTION……………………………………….…........1 a. Bile Acid Synthesis…………………………………………….……….2 i. Importance of Bile Acid Synthesis Pathway………………….….....2 ii. Bile Acid Transport..…………………………………...…...………...3 iii. Bile Acid Synthesis Pathway………………………………………...…4 iv. Classical Bile Acid Synthesis Pathway…..……………………..…..8 Cholesterol 7 -hydroxylase (CYP7A1)……..........………….....8 Transcriptional Regulation of Cholesterol 7 -hydroxylase by Bile Acid-activated FXR…………………………….....…10 CYP7A1 Transcriptional Repression by SHP-dependant Mechanism…………………………………………………...10 CYP7A1 Transcriptional Repression by SHP-independent Mechanism……………………………………..…………….…….11 CYP7A1 Transcriptional Repression by Activated Cellular Kinase…….…………………………...…………………….……12 v. Alternative/ Acidic Bile Acid Synthesis Pathway…………......…….12 Sterol 27-hydroxylase (CYP27A1)……………….…………….12
[Show full text]
Vitamin D Receptor (VDR) and Cholesterol Homeostasis: Interplay of VDR Enzyme Targets and Vitamin D Deficiency
Vitamin D Receptor (VDR) and Cholesterol Homeostasis: Interplay of VDR Enzyme Targets and Vitamin D Deficiency by Holly P. Quach A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy Department of Pharmaceutical Sciences University of Toronto © Copyright by Holly P. Quach, 2016 Vitamin D Receptor (VDR) and Cholesterol Homeostasis: Interplay of VDR Enzyme Targets and Vitamin D Deficiency Holly P. Quach Doctor of Philosophy Department of Pharmaceutical Sciences University of Toronto 2016 Abstract Vitamin D deficiency is speculated to play a role in hypercholesterolemia. However, there has been little molecular evidence to link the two until recent evidence identified the vitamin D receptor (VDR) and its natural ligand, 1α,25-dihydroxyvitamin D3 [1,25(OH)2D3], as key regulators of cholesterol metabolism. In the liver, 1,25(OH)2D3-liganded VDR directly inhibited the small heterodimer partner (Shp) to increase expression of cholesterol 7α-hydroxylase (Cyp7a1), the rate-limiting enzyme for cholesterol metabolism to bile acids, a mechanism independent of the farnesoid X receptor. Vitamin D deficiency was established in mice after 8 weeks of the D-deficient diet, which resulted in decreased levels of plasma and liver 1,25(OH)2D3, downregulation of hepatic Vdr and Cyp7a1, and elevation of Shp. Consequently, higher plasma and liver cholesterol levels were observed. Intervention with 1,25(OH)2D3 or vitamin D3 reversed the altered expression of these cholesterol-regulating genes and lowered cholesterol levels back to baseline levels. The correlations between liver cholesterol vs. liver 1,25(OH)2D3 and Cyp7a1 expression in mice were also found in human liver tissue, suggesting that the VDR could be a ii potential therapeutic target for cholesterol lowering.
[Show full text]
Expression of CYP2S1 in Human Hepatic Stellate Cells
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector FEBS Letters 581 (2007) 781–786 Expression of CYP2S1 in human hepatic stellate cells Carylyn J. Mareka, Steven J. Tuckera, Matthew Korutha, Karen Wallacea,b, Matthew C. Wrighta,b,* a School of Medical Sciences, Institute of Medical Science, University of Aberdeen, Aberdeen, UK b Liver Faculty Research Group, School of Clinical and Laboratory Sciences, University of Newcastle, Newcastle, UK Received 22 November 2006; revised 16 January 2007; accepted 23 January 2007 Available online 2 February 2007 Edited by Laszlo Nagy the expression and accumulation of scarring extracellular Abstract Activated stellate cells are myofibroblast-like cells associated with the generation of fibrotic scaring in chronically fibrotic matrix protein [2]. It is currently thought an inhibition damaged liver. Gene chip analysis was performed on cultured fi- of fibrosis in liver diseases may be an effective approach to brotic stellate cells. Of the 51 human CYP genes known, 13 treating patients for which the cause is refractive to current CYP and 5 CYP reduction-related genes were detected with 4 treatments (e.g. in approx. 30% of hepatitis C infected CYPs (CYP1A1, CYP2E1, CY2S1 and CYP4F3) consistently patients) [2,3]. At present, there is no approved treatment for present in stellate cells isolated from three individuals. Quantita- fibrosis. tive RT-PCR indicated that CYP2S1 was a major expressed Inadvertent toxicity of drugs is often associated with a ‘‘met- CYP mRNA transcript. The presence of a CYP2A-related pro- abolic activation’’ by CYPs [1].
[Show full text]
Regulation of Cytochrome P450 (CYP) Genes by Nuclear Receptors Paavo HONKAKOSKI*1 and Masahiko NEGISHI† *Department of Pharmaceutics, University of Kuopio, P
Biochem. J. (2000) 347, 321–337 (Printed in Great Britain) 321 REVIEW ARTICLE Regulation of cytochrome P450 (CYP) genes by nuclear receptors Paavo HONKAKOSKI*1 and Masahiko NEGISHI† *Department of Pharmaceutics, University of Kuopio, P. O. Box 1627, FIN-70211 Kuopio, Finland, and †Pharmacogenetics Section, Laboratory of Reproductive and Developmental Toxicology, NIEHS, National Institutes of Health, Research Triangle Park, NC 27709, U.S.A. Members of the nuclear-receptor superfamily mediate crucial homoeostasis. This review summarizes recent ﬁndings that in- physiological functions by regulating the synthesis of their target dicate that major classes of CYP genes are selectively regulated genes. Nuclear receptors are usually activated by ligand binding. by certain ligand-activated nuclear receptors, thus creating tightly Cytochrome P450 (CYP) isoforms often catalyse both formation controlled networks. and degradation of these ligands. CYPs also metabolize many exogenous compounds, some of which may act as activators of Key words: endobiotic metabolism, gene expression, gene tran- nuclear receptors and disruptors of endocrine and cellular scription, ligand-activated, xenobiotic metabolism. INTRODUCTION sex-, tissue- and development-speciﬁc expression patterns which are controlled by hormones or growth factors [16], suggesting Overview of the cytochrome P450 (CYP) superfamily that these CYPs may have critical roles, not only in elimination CYPs constitute a superfamily of haem-thiolate proteins present of endobiotic signalling molecules, but also in their production in prokaryotes and throughout the eukaryotes. CYPs act as [17]. Data from CYP gene disruptions and natural mutations mono-oxygenases, with functions ranging from the synthesis and support this view (see e.g. [18,19]). degradation of endogenous steroid hormones, vitamins and fatty Other mammalian CYPs have a prominent role in biosynthetic acid derivatives (‘endobiotics’) to the metabolism of foreign pathways.
[Show full text]
Maternal High-Fat Diet Programs Offspring Liver Steatosis in A
www.nature.com/scientificreports OPEN Maternal High-Fat Diet Programs Ofspring Liver Steatosis in a Sexually Dimorphic Manner in Received: 1 March 2018 Accepted: 15 October 2018 Association with Changes in Gut Published: xx xx xxxx Microbial Ecology in Mice Umesh D. Wankhade 1,2, Ying Zhong2, Ping Kang2, Maria Alfaro3, Sree V. Chintapalli1,2, Brian D. Piccolo1,2, Kelly E. Mercer1,2, Aline Andres1,2, Keshari M. Thakali1,2 & Kartik Shankar1,2 The contributions of maternal diet and obesity in shaping ofspring microbiome remain unclear. Here we employed a mouse model of maternal diet-induced obesity via high-fat diet feeding (HFD, 45% fat calories) for 12 wk prior to conception on ofspring gut microbial ecology. Male and female ofspring were provided access to control or HFD from weaning until 17 wk of age. Maternal HFD-associated programming was sexually dimorphic, with male ofspring from HFD dams showing hyper-responsive weight gain to postnatal HFD. Likewise, microbiome analysis of ofspring cecal contents showed diferences in α-diversity, β-diversity and higher Firmicutes in male compared to female mice. Weight gain in ofspring was signifcantly associated with abundance of Lachnospiraceae and Clostridiaceae families and Adlercreutzia, Coprococcus and Lactococcus genera. Sex diferences in metagenomic pathways relating to lipid metabolism, bile acid biosynthesis and immune response were also observed. HFD-fed male ofspring from HFD dams also showed worse hepatic pathology, increased pro-infammatory cytokines, altered expression of bile acid regulators (Cyp7a1, Cyp8b1 and Cyp39a1) and serum bile acid concentrations. These fndings suggest that maternal HFD alters gut microbiota composition and weight gain of ofspring in a sexually dimorphic manner, coincident with fatty liver and a pro-infammatory state in male ofspring.
[Show full text]
Animal Models to Study Bile Acid Metabolism T ⁎ Jianing Li, Paul A
BBA - Molecular Basis of Disease 1865 (2019) 895–911 Contents lists available at ScienceDirect BBA - Molecular Basis of Disease journal homepage: www.elsevier.com/locate/bbadis ☆ Animal models to study bile acid metabolism T ⁎ Jianing Li, Paul A. Dawson Department of Pediatrics, Division of Gastroenterology, Hepatology, and Nutrition, Emory University, Atlanta, GA 30322, United States ARTICLE INFO ABSTRACT Keywords: The use of animal models, particularly genetically modified mice, continues to play a critical role in studying the Liver relationship between bile acid metabolism and human liver disease. Over the past 20 years, these studies have Intestine been instrumental in elucidating the major pathways responsible for bile acid biosynthesis and enterohepatic Enterohepatic circulation cycling, and the molecular mechanisms regulating those pathways. This work also revealed bile acid differences Mouse model between species, particularly in the composition, physicochemical properties, and signaling potential of the bile Enzyme acid pool. These species differences may limit the ability to translate findings regarding bile acid-related disease Transporter processes from mice to humans. In this review, we focus primarily on mouse models and also briefly discuss dietary or surgical models commonly used to study the basic mechanisms underlying bile acid metabolism. Important phenotypic species differences in bile acid metabolism between mice and humans are highlighted. 1. Introduction characteristics such as small size, short gestation period and life span, which facilitated large-scale laboratory breeding and housing, the Interest in bile acids can be traced back almost three millennia to availability of inbred and specialized strains as genome sequencing the widespread use of animal biles in traditional Chinese medicine [1].
[Show full text]
Srebp2 and Reverb-Alpha Regulation of Human Cyp8b1
SREBP2 AND REVERB-ALPHA REGULATION OF HUMAN CYP8B1 A thesis submitted to Kent State University in partial fulfillment of the requirements for the Degree of Master of Sciences By Hailin Feng December, 2009 Thesis written by Hailin Feng B.S. Guangzhou University, 1992 M.S. Guangzhou Medical College, 1995 M.S. Kent State University, 2009 Approved by ________________________________, Advisor Dr. John Y. Chiang ________________________________, Director, School of Biomedical Science Dr. Robert V. Dorman ________________________________, Dean, College of Arts and Sciences Dr. John R.D. Stalvey ii TABLE OF CONTENTS LIST OF FIGURES………………………………………………………………….vi ACKNOWLEGEMENTS……………………………………………………………viii CHAPTER I INTRODUCTION…………………………………………………………….1 1. Bile Acids………………………………………………………………..…2 1.1 Structure and function……………………………………………………..2 1.2 Synthesis pathways and enzymes………………………………………….5 1.2.1 Classic pathway………………………………………………………….5 1.2.2 Acidic pathway………………………………………………………….6 1.3 Regulation of bile acid synthesis…………………………………………..7 1.3.1 Cholesterol homeostasis…………………………………………………7 1.3.2 Enterohepatic circulation of bile………………………………………..10 2. Nuclear Hormone Receptor…………………………………………….…..10 2.1 Structure………………………………………………………………......10 2.2 Response elements………………………………………………………..15 2.3 Ligands……………………………………………………………….…...16 3. Hormone Receptors Related to Bile Acid Synthesis………………….……16 3.1 Hepatocyte nuclear factor 4α (HNF4α, NR2A1)……………………..…..16 3.2 Farnesoid receptor (FXR, NR1H4)……………………………………….17 iii 3.3 Human α-fetoprotein transcription
[Show full text]
Biodiversity of P-450 Monooxygenase: Cross-Talk
Cytochrome P450: Oxygen activation and biodiversty 1 Biodiversity of P-450 monooxygenase: Cross-talk between chemistry and biology Heme Fe(II)-CO complex 450 nm, different from those of hemoglobin and other heme proteins 410-420 nm. Cytochrome Pigment of 450 nm Cytochrome P450 CYP3A4…. 2 High Energy: Ultraviolet (UV) Low Energy: Infrared (IR) Soret band 420 nm or g-band Mb Fe(II) ---------- Mb Fe(II) + CO - - - - - - - Visible region Visible bands Q bands a-band, b-band b a 3 H2O/OH- O2 CO Fe(III) Fe(II) Fe(II) Fe(II) Soret band at 420 nm His His His His metHb deoxy Hb Oxy Hb Carbon monoxy Hb metMb deoxy Mb Oxy Mb Carbon monoxy Mb H2O/Substrate O2-Substrate CO Substrate Soret band at 450 nm Fe(III) Fe(II) Fe(II) Fe(II) Cytochrome P450 Cys Cys Cys Cys Active form 4 Monooxygenase Reactions by Cytochromes P450 (CYP) + + RH + O2 + NADPH + H → ROH + H2O + NADP RH: Hydrophobic (lipophilic) compounds, organic compounds, insoluble in water ROH: Less hydrophobic and slightly soluble in water. Drug metabolism in liver ROH + GST → R-GS GST: glutathione S-transferase ROH + UGT → R-UG UGT: glucuronosyltransferaseGlucuronic acid Insoluble compounds are converted into highly hydrophilic (water soluble) compounds. 5 Drug metabolism at liver: Sleeping pill, pain killer (Narcotic), carcinogen etc. Synthesis of steroid hormones (steroidgenesis) at adrenal cortex, brain, kidney, intestine, lung, Animal (Mammalian, Fish, Bird, Insect), Plants, Fungi, Bacteria 6 NSAID: non-steroid anti-inflammatory drug 7 8 9 10 11 Cytochrome P450: Cysteine-S binding to Fe(II) heme is important for activation of O2.
[Show full text]
Hepatic Cytochrome P450 Reductase-Null Mice As an Animal Model to Study Electron Transfer Pathways in Cholesterol Synthesis and Cyp2e1-Mediated Drug Metabolism
University of Kentucky UKnowledge University of Kentucky Doctoral Dissertations Graduate School 2006 HEPATIC CYTOCHROME P450 REDUCTASE-NULL MICE AS AN ANIMAL MODEL TO STUDY ELECTRON TRANSFER PATHWAYS IN CHOLESTEROL SYNTHESIS AND CYP2E1-MEDIATED DRUG METABOLISM Li Li University of Kentucky, [email protected] Right click to open a feedback form in a new tab to let us know how this document benefits ou.y Recommended Citation Li, Li, "HEPATIC CYTOCHROME P450 REDUCTASE-NULL MICE AS AN ANIMAL MODEL TO STUDY ELECTRON TRANSFER PATHWAYS IN CHOLESTEROL SYNTHESIS AND CYP2E1-MEDIATED DRUG METABOLISM" (2006). University of Kentucky Doctoral Dissertations. 417. https://uknowledge.uky.edu/gradschool_diss/417 This Dissertation is brought to you for free and open access by the Graduate School at UKnowledge. It has been accepted for inclusion in University of Kentucky Doctoral Dissertations by an authorized administrator of UKnowledge. For more information, please contact [email protected]. ABSTRACT OF DISSERTATION Li Li The Graduate School University of Kentucky 2006 HEPATIC CYTOCHROME P450 REDUCTASE-NULL MICE AS AN ANIMAL MODEL TO STUDY ELECTRON TRANSFER PATHWAYS IN CHOLESTEROL SYNTHESIS AND CYP2E1-MEDIATED DRUG METABOLISM ABSTRACT OF DISSERTATION A dissertation submitted in partial fulfillment of the requirements of the degree of Doctor of Philosophy in The Graduate School at the University of Kentucky By Li Li Lexington, Kentucky Director: Dr. Todd D. Porter, Associate Professor of Pharmaceutical Sciences College of Pharmacy 2006 Copyright © Li Li 2006 ABSTRACT OF DISSERTATION HEPATIC CYTOCHROME P450 REDUCTASE-NULL MICE AS AN ANIMAL MODEL TO STUDY ELECTRON TRANSFER PATHWAYS IN CHOLESTEROL SYNTHESIS AND CYP2E1-MEDIATED DRUG METABOLISM NADPH-cytochrome P450 reductase (CPR) is a flavoprotein containing both FAD and FMN and functions as the electron donor protein for several oxygenase enzymes found on the endoplasmic reticulum of eukaryotic cells, including cytochrome P450s involved in drug metabolism and cholesterol biosynthesis.
[Show full text]
Orphan Nuclear Receptor Rorα Regulates Enzymatic Metabolism of Cerebral 24S-Hydroxycholesterol Through CYP39A1 Intronic Response Element Activation
International Journal of Molecular Sciences Article Orphan Nuclear Receptor RORα Regulates Enzymatic Metabolism of Cerebral 24S-Hydroxycholesterol through CYP39A1 Intronic Response Element Activation Hiroshi Matsuoka 1,* , Miyu Katayama 1, Ami Ohishi 1, Kaoruko Miya 1, Riki Tokunaga 1, Sou Kobayashi 1, Yuya Nishimoto 1, Kazutake Hirooka 2 , Akiho Shima 1 and Akihiro Michihara 1 1 Laboratory of Genome Function and Pathophysiology, Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, Fukuyama, Hiroshima 729-0292, Japan; [email protected] (M.K.); [email protected] (A.O.); [email protected] (K.M.); [email protected] (R.T.); [email protected] (S.K.); [email protected] (Y.N.); [email protected] (A.S.); [email protected] (A.M.) 2 Department of Biotechnology, Faculty of Life Science and Biotechnology, Fukuyama University, Fukuyama, Hiroshima 729-0292, Japan; [email protected] * Correspondence: [email protected]; Tel.: +81-84-936-2111 Received: 2 April 2020; Accepted: 6 May 2020; Published: 7 May 2020 Abstract: Oxysterols, important regulators of cholesterol homeostasis in the brain, are affected by neurodegenerative diseases. Early-onset Alzheimer’s disease is associated with higher levels of circulating brain-derived 24S-hydroxycholesterol (24S-OHC). Conversion of cholesterol to 24S-OHC is mediated by cholesterol 24S-hydroxylase in the brain, which is the major pathway for oxysterol elimination, followed by oxidation through hepatic first-pass metabolism by CYP39A1. Abnormal CYP39A1 expression results in accumulation of 24S-OHC, influencing neurodegenerative disease-related deterioration; thus, it is important to understand the normal elimination of 24S-OHC and the system regulating CYP39A1, a selective hepatic metabolic enzyme of 24S-OHC.
[Show full text]